ELECTRODIAGNOSIS History @ Toronto General Hospital : Late Dr.John Gilchrist HUMPHREY

ELECTRODIAGNOSIS Dept.at Toronto General Hospital was founded by Assoc.Prof JOHN GILCHRIST HUMPHREY MD(Tor. 1954) FRCPC (1928-1991)Trained at London Institute of Neurology (R.W.Gilliatt & R.G.Willison). Obituary in Globe & Mail. Reason for post. Details not on web.

OLYMPIC FEMALE HOCKEY: Population Health

SWITZERLAND 3rd with female popn 4-million.(All private medical insurance) CANADA 1rst with female popn 17-million (mainly free State insurance, except Quebec which permits Private medicine) USA 2nd with female popn 159-million (Mixed private, and subsidized medicine)

VACANCY: PRESIDENT PUBLIC HEALTH ONTARIO

On 19 February 2014 11:10, PHO Communications wrote: Public Health Ontario’s President and CEO, Dr. Vivek Goel, will be leaving the organization in May 2014 after six years. The Board of Directors is working closely with PHO’s executive team to manage the transition and a search for a new leader will be launched shortly. (comment MHSc & MSc(Biostatistics) an advantage( In serving as PHO’s founding President and CEO, Dr. Goel oversaw the establishment of the agency, guided the renewal of the public health laboratories and many provincial health protection programs, and assembled unique talent and expertise. His academic and scientific leadership positions Public Health Ontario well for ongoing success. Prior to joining PHO, Goel was vice-president and provost at the University of Toronto. Upon leaving Public Health Ontario, he returns to academe by joining California company Coursera as their Chief Academic Strategist. https://www.coursera.org Vivek Goel MD,CM, MSc, SM, FRCPC Contact Information Email Address: vivek.goel@utoronto.ca Office Phone Number: 647-260-7111 Public Health Ontario 480 University Avenue, 3rd floor Toronto ON M5G 1V2 Website(s): www.oahpp.ca Dr. Vivek Goel is president and chief executive officer of Public Health Ontario, an arm's-length government agency dedicated to protecting and promoting the health of all Ontarians and reducing inequities in health. As a hub organization, PHO links public health practitioners, front-line health workers and researchers to the best scientific intelligence and knowledge from around the world. PHO provides expert scientific and technical support relating to infection prevention and control; surveillance and epidemiology; health promotion, chronic disease and injury prevention; environmental and occupational health; health emergency preparedness; and public health laboratory services to support health providers, the public health system and partner ministries in making informed decisions and taking informed action to improve the health and security of Ontarians. Dr. Goel brings extensive experience in health care evaluation and research to this role. He has been engaged in a broad range of research activities related to public health, particularly focusing on chronic disease prevention and control. These research activities include the economic evaluation of health care interventions, optimization of the use of laboratory tests in the periodic health examination and the development of measures for health status assessment. In addition, Dr. Goel has served on numerous local, provincial and federal committees related to public health as well as being involved in international activities. Prior to joining the PHO in 2008, he served five years as vice-president and provost at the University of Toronto. Dr. Goel joined the University of Toronto as an assistant professor in the Department of Preventive Medicine and Biostatistics in 1991. He was chair of the Department of Health Administration in the Faculty of Medicine from 1999 until 2001 and served in the University’s senior administration as vice-provost, faculty from 2001 to 2004. He was president of the Central East Health Information Partnership, an Ontario Ministry of Health and Long-Term Care funded health intelligence unit. From 1999 to 2002 he was the scientific program leader at the Health Evidence Applications Linkages Network (HEALNet), a federal network of centres of excellence. Dr. Goel is a licensed physician and Fellow of the Royal College of Physicians of Canada, having obtained his medical degree from McGill University. He did his post-graduate medical training in community medicine at the University of Toronto and also obtained a Master’s degree (M.Sc.) in health administration from the University of Toronto and a Master’s degree (S.M.) in biostatistics from Harvard University’s School of Public Health.

Ont PublicService Retiree benefits. (NONE FOR OMA MEMBERS).

News Release Ontario Updates Public Sector Retiree Benefit Plans February 18, 2014 Sharing Cost Of Retiree Benefits Equally With Ontario Public Sector Employees The Ontario government will transition to a cost-sharing model for retiree benefits for employees retiring on or after Jan. 1, 2017. This will bring Ontario Public Service retiree benefits in line with other public sector organizations where retirees are often asked to contribute up to 100 per cent of their benefits premium. Current retirees from the Ontario Public Service will not be affected by these changes. Key features of the new model will: Require employees retiring on or after Jan. 1, 2017 to pay 50 per cent of their benefits premiums (e.g. life, health, dental and vision). Currently the government pays 100 per cent. Change the eligibility period for retiree benefits from 10 to 20 years for employees hired on or after Jan. 1, 2017. Taking a measured and moderate approach to Ontario's finances is part of the government's economic plan that is creating jobs for today and tomorrow. The comprehensive plan and its six priorities focus on Ontario's greatest strengths - its people and strategic partnerships. QUICK FACTS Employees who do not have 10 years pension credit in the pension plans by Jan. 1, 2017 will have to have at least 20 years of pension credits and retire to an immediate unreduced pension in order to qualify for retiree benefits. About 3,000 - 4,000 employees begin to receive a pension and retiree benefits from the Public Service Pension Plan or the OPSEU Pension Plan each year. There are more than 84,000 active members of the Ontario Public Service and other employers enrolled in Ontario Public Service pension plans. Retiree benefits are not a provision of the pension plans nor are they a pension benefit. (COMMENT Ont.MDs do not have similar juicy perks. They are Ont.Govt.CONTRACT WORKERS with FIXED RATES of PAY with the legal fiction of being "self-employed".)

Princess Margaret Cancer Hospital TOWN vs GOWN Patient care vs Research.

Life depends on choice of Cancer Hospital. In State medicine OHIP pays the same to Triple A and House League Cancer docs. The perks of First Class travel to International Conferences as an Invited Speaker comes to those who organise TRIALS. There is an conflict of interest between giving the Best available treatment to the Individual and the value of the person in a Trial. Patients are given papers to sign however Statistics Canada figures find that 46% of Canucks are FUNCTIONALLY ILLITERATE. They can read simple texts but can't fill forms. Immuno-compromized patients need high level of Hospital hygiene. The appearance of Staff does not give confidence. Habd-washing is not evident. Only the use of less-than-effective Ethyl alcohol gel. (ODETTE CANCER CENTRE @ SUNNYBROOK Hosp has higher level of hygiene and patient care. Possibly due to its location near the most wealthy part of Toronto: The Bridle Path)

FIBROSCAN: vibration-controlled transient elastography (VCTE).to estimate Hep.fibrosis & controlled attenuation parameter for Hep steatosis.

wwww.liverscan.ca $100 FEE NOT PAID BY Ont.Govt insurance(OHIP). NO NEED FOR GP REFERRAL. Liver Scan Direct is a medical diagnostics clinic based in Toronto that specializes in the non-invasive assessment of liver health using FibroScan® technology. Our mission is to provide patients who have liver problems rapid access to FibroScan® testing with interpretation of results by an internationally recognized expert (Dr. Robert P. Myers). Why wait months for a referral to a liver or gastroenterology specialist and then wait longer to undergo an invasive liver biopsy? No referral is necessary to be assessed at Liver Scan Direct. Any patient can contact us directly to schedule an appointment. We schedule appointments rapidly and provide results within 1-2 business days. In order to improve access for physicians and their patients with liver disease, Liver Scan Direct now offers FibroScan® clinics in 10 locations in southern Ontario (Toronto, Mississauga, Scarborough, Richmond Hill, Newmarket, Burlington, Waterloo, and Guelph). Dr. Robert P. Myers, MD, MSc, FRCPC Liver Scan Direct's medical consultant - Dr. Robert Myers - is an Associate Professor of Medicine, Hepatologist, and Director of the Viral Hepatitis Clinic at the University of Calgary. He is an internationally-recognized expert on the non-invasive assessment of liver disease, particularly FibroScan technology. Dr. Myers has published over 110 scientific studies, including the 2012 Canadian consensus guidelines for the management of hepatitis C (see below). Dr. Myers frequently lectures on this technology at international scientific meetings. Dr. Myers is an Associate Editor of the American Journal of Gastroenterology, a member of the Editorial Board of Hepatology (the premier journal in the field), past Chair of the Education Committee of the Canadian Association for the Study of the Liver, and a member of the National Education Advisory Committee of the Canadian Liver Foundation. In 2012, Dr. Myers was awarded a Queen Elizabeth II Diamond Jubilee Medal for his contributions to research and patient care in liver disease. Dr Robert Myers Selected FibroScan Publications by Dr. Myers 1. RP Myers, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55(1):199-208. ​ 2. RP Myers, et al. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol 2013; 12(1):100-7. ​ 3. Myers RP, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012;32(6):902-10. ​ 4. RP Myers, et al. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol 2010;24(11):661-70.  5. RP Myers, et al. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26(6):359-75.

CMAJ: LACRIMAL GLAND CALCULI

Lacrimal Gland Duct Stones Misdiagnosed as Chalazion This report is of three patients with lacrimal gland duct stones that were misdiagnosed as chalazion at a local clinic between 2010 and 2012. A review of clinical, imaging, and histopathologic manifestations are discussed. Clinical manifestations of lacrimal gland duct stones included conjunctival injection, lid swelling, tenderness, and ocular discharge, which are similar to chalazion symptoms. Computed tomography revealed a relatively well-defined, high-density mass near the lacrimal gland. Histopathologic examination of excised material revealed calcified amorphous stones. Intractable chalazion-like lesions at the lateral canthal area near the lacrimal gland should be carefully examined; imaging studies are required to confirm the presence of lacrimal gland duct stones, which require surgical removal. SOURCE: Kim SC, Lee K, Lee SU. Lacrimal gland duct stones: misdiagnosed as chalazion in 3 cases. Can J Ophthalmol. 2014;49(1):102–5.